Skip to main content
DC 5025Musculoskeletal System

Secondary Conditions for Fibromyalgia

5 conditions have documented medical links to Fibromyalgia. These may qualify as secondary service-connected disabilities if you can establish a medical nexus.

Evidence Strength:STRONGMODERATEEMERGING
STRONG

Medical Rationale

Fibromyalgia and chronic fatigue syndrome share overlapping central sensitization pathways and co-occur in 35-70% of cases. The central nervous system amplification of sensory input in fibromyalgia extends beyond pain to produce pathological fatigue through several mechanisms: chronic microglial activation in the brainstem reticular formation disrupts arousal pathways, elevated substance P and glutamate in cerebrospinal fluid produce excitotoxic neuronal stress that depletes ATP, and non-restorative sleep from alpha-wave intrusion into delta sleep prevents normal physical recovery. The overlapping inflammatory cytokine profiles (elevated IL-1, IL-6, TNF-alpha) suggest a shared neuroimmune mechanism. The two conditions are rated separately under distinct diagnostic codes.

Key Studies

Aaron LA et al. (2000) Arch Intern Med (fibromyalgia and CFS overlap); Clauw DJ (2014) JAMA (fibromyalgia central sensitization); Naschitz JE et al. (2008) Autoimmun Rev (shared pathophysiology).

Filing Tips

Document persistent fatigue lasting >6 months not explained by other causes. Rheumatology or internal medicine records diagnosing CFS/ME with fibromyalgia as the inciting condition. Fatigue severity rating scales (FSS, Chalder Fatigue Scale). Rheumatology nexus letter addressing the shared central sensitization mechanism. VA rates CFS under DC 6354 separately from fibromyalgia (DC 5025) — document how fatigue impacts occupational functioning independently of pain.

STRONG

Medical Rationale

Fibromyalgia produces IBS through visceral hyperalgesia — the same central sensitization that amplifies somatic pain also amplifies visceral pain signaling from the gut-brain axis. The dorsal horn wind-up and reduced descending inhibition in fibromyalgia lower the pain threshold for normal gut distension and peristalsis, producing the abdominal pain, bloating, and altered bowel habits of IBS. Additionally, the autonomic dysregulation in fibromyalgia (predominantly sympathetic hyperactivity) disrupts gut motility and secretion. Elevated mast cell counts in the colonic mucosa of fibromyalgia patients release histamine and serotonin that further sensitize visceral afferents. Studies show IBS prevalence of 32-70% in fibromyalgia patients versus 8-12% in the general population.

Key Studies

Sperber AD et al. (1999) Dig Dis Sci (IBS and fibromyalgia overlap — 32-70%); Barton A et al. (1999) Eur J Gastroenterol Hepatol (central sensitization in fibromyalgia and IBS); Chang L (2011) Nat Rev Gastroenterol Hepatol (visceral hyperalgesia).

Filing Tips

GI evaluation documenting IBS diagnosis with symptom onset after fibromyalgia diagnosis. Document diarrhea-predominant, constipation-predominant, or mixed IBS subtype. GI or rheumatology nexus letter addressing visceral hyperalgesia and central sensitization as the shared mechanism. Keep a bowel symptom diary for 2-4 weeks before C&P exam. VA rates IBS under DC 7319 — severe IBS with diarrhea or alternating episodes causing more or less constant abdominal distress is rated 30%.

STRONG

Medical Rationale

Fibromyalgia and major depression have a robust, bidirectional comorbid relationship rooted in shared pathophysiology. Fibromyalgia is fundamentally a central sensitization syndrome involving dysfunction of the serotonin-norepinephrine neurotransmitter systems in descending pain modulation pathways — the identical systems implicated in MDD pathophysiology. Serotonin and norepinephrine deficiency in the brainstem's descending inhibitory pathways impair both pain modulation (→ fibromyalgia) and mood regulation (→ depression) simultaneously. Studies consistently show major depression comorbidity in 30–50% of fibromyalgia patients. The chronic unrelenting pain, sleep disruption, and functional disability of fibromyalgia create powerful secondary psychological stressors that independently precipitate depressive episodes. The effectiveness of SNRIs (duloxetine, milnacipran) in treating both fibromyalgia pain and depression confirms their shared neurochemical basis.

Key Studies

Arnold LM et al. (2006) Pain (fibromyalgia and depression neurobiological overlap); Hauser W et al. (2011) Arthritis Res Ther (fibromyalgia and psychiatric comorbidity meta-analysis); Gracely RH et al. (2004) Pain (central sensitization in fibromyalgia); Clauw DJ (2014) JAMA (fibromyalgia review).

Filing Tips

Psychiatric records documenting major depression diagnosis. Rheumatology records documenting fibromyalgia diagnosis and severity. A nexus letter from your rheumatologist and/or psychiatrist addressing the shared serotonin-norepinephrine neurotransmitter dysfunction and the chronic pain burden as dual causes of depression. If fibromyalgia is service-connected (whether direct or secondary to GWI), depression can be filed as secondary to fibromyalgia.

STRONG

Medical Rationale

Fibromyalgia produces TMJ dysfunction through central sensitization affecting the masticatory system and stress-mediated bruxism. The trigeminal nucleus, which processes orofacial pain, is subject to the same central sensitization wind-up that characterizes fibromyalgia throughout the body. This lowers the pain threshold for normal TMJ function (chewing, talking, yawning). Additionally, the chronic pain and psychological stress of fibromyalgia drive nocturnal and diurnal bruxism — clenching and grinding that overloads the TMJ disc and capsule. Myofascial trigger points in the masticatory muscles (masseter, temporalis, lateral pterygoid) are nearly universal in fibromyalgia. Studies show TMJ dysfunction prevalence of 75-97% in fibromyalgia patients.

Key Studies

Plesh O et al. (1996) J Rheumatol (TMD and fibromyalgia — 75% prevalence); Hedenberg-Magnusson B et al. (1999) Acta Odontol Scand (orofacial pain in fibromyalgia); Balasubramaniam R et al. (2007) Oral Surg Oral Med Oral Pathol Oral Radiol Endod (fibromyalgia and TMD).

Filing Tips

Dental or oral surgery evaluation documenting TMJ dysfunction. Imaging showing TMJ disc displacement or degenerative changes. Document jaw pain, limited opening, clicking/popping, and headaches from TMJ dysfunction. Oral surgeon or rheumatology nexus letter addressing central sensitization of the masticatory system. VA rates TMJ under DC 9905 — limited motion of the temporomandibular articulation. Measure inter-incisal range at C&P exam.

STRONG

Medical Rationale

Chronic opioid therapy produces hypogonadotropic hypogonadism (opioid-induced androgen deficiency, OPIAD) in 50-90% of men and causes menstrual irregularities in women. Opioids suppress gonadotropin-releasing hormone (GnRH) pulsatility in the hypothalamus, reducing LH and FSH secretion from the anterior pituitary and consequently decreasing testicular testosterone production. This endocrine disruption occurs within days of initiating opioid therapy and persists throughout treatment. The resulting testosterone deficiency produces fatigue, depression, decreased libido, erectile dysfunction, muscle wasting, osteoporosis, and metabolic syndrome. The severity of hypogonadism correlates with opioid dose — morphine equivalent doses >100 mg/day produce clinically significant testosterone suppression in virtually all male patients.

Key Studies

Rubinstein AL & Carpenter DM (2014) Pain Med (opioid-induced androgen deficiency — systematic review); Bawor M et al. (2015) J Addict Med (testosterone suppression in opioid users — meta-analysis).

Filing Tips

Morning serum testosterone level (drawn before 10 AM) documenting hypogonadism (<300 ng/dL). LH and FSH levels documenting central (hypogonadotropic) etiology. Pharmacy records documenting chronic opioid use for service-connected pain condition. Endocrinology or pain medicine nexus letter addressing GnRH suppression mechanism. Document all downstream symptoms: fatigue, depression, ED, osteoporosis. File under DC 7523 (testis, complete atrophy) or most analogous endocrine code. Each downstream condition (ED, depression, osteoporosis) can potentially be filed as a separate secondary claim.

← Back to Fibromyalgia rating criteria

Find All Secondary Conditions for Your Situation

AIDEN can analyze your complete medical history and identify secondary conditions specific to your case, including connections that may not appear in standard databases.

Discover Your Secondary Conditions